Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Mechanism of activation and inhibition of the HER4/ErbB4 kinase.

Qiu C, Tarrant MK, Choi SH, Sathyamurthy A, Bose R, Banjade S, Pal A, Bornmann WG, Lemmon MA, Cole PA, Leahy DJ.

Structure. 2008 Mar;16(3):460-7. doi: 10.1016/j.str.2007.12.016.

2.

The ErbB/HER receptor protein-tyrosine kinases and cancer.

Roskoski R Jr.

Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. Review.

PMID:
15158434
3.

The ErbB/HER family of protein-tyrosine kinases and cancer.

Roskoski R Jr.

Pharmacol Res. 2014 Jan;79:34-74. doi: 10.1016/j.phrs.2013.11.002. Epub 2013 Nov 20. Review.

PMID:
24269963
4.

Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.

Subramaniam D, He AR, Hwang J, Deeken J, Pishvaian M, Hartley ML, Marshall JL.

Curr Cancer Drug Targets. 2015;14(9):775-93. Review.

PMID:
25435079
5.

The ErbB kinase domain: structural perspectives into kinase activation and inhibition.

Bose R, Zhang X.

Exp Cell Res. 2009 Feb 15;315(4):649-58. doi: 10.1016/j.yexcr.2008.07.031. Epub 2008 Aug 15. Review.

6.

Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors.

Cruz-López O, Conejo-García A, Núñez MC, Kimatrai M, García-Rubiño ME, Morales F, Gómez-Pérez V, Campos JM.

Curr Med Chem. 2011;18(7):943-63. Review.

PMID:
21254978
7.

The neuregulin-I/ErbB signaling system in development and disease.

Britsch S.

Adv Anat Embryol Cell Biol. 2007;190:1-65. Review.

PMID:
17432114
8.

The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.

Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C, Schmidt-Ullrich RK.

Oncogene. 2001 Mar 15;20(11):1388-97. Review. Erratum in: Oncogene 2001 Jun 28;20(29):3927.

9.

ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.

Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS 3rd.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):235-46. doi: 10.1007/s10911-008-9080-x. Epub 2008 Apr 25. Review.

10.

Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity.

Montemurro F, Valabrega G, Aglietta M.

Expert Opin Biol Ther. 2007 Feb;7(2):257-68. Review.

PMID:
17250463
11.

Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms.

Jura N, Zhang X, Endres NF, Seeliger MA, Schindler T, Kuriyan J.

Mol Cell. 2011 Apr 8;42(1):9-22. doi: 10.1016/j.molcel.2011.03.004. Review.

12.

Role of ErbB4 in breast cancer.

Sundvall M, Iljin K, Kilpinen S, Sara H, Kallioniemi OP, Elenius K.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):259-68. doi: 10.1007/s10911-008-9079-3. Epub 2008 May 3. Review.

PMID:
18454307

Supplemental Content

Support Center